DaVita Q2 Profit Jumps 56% to $4.02/Share, Revenue Up 5.2%
DVA has more than doubled off its 52-week low of $101 on elevated volume (2.8× avg).
Summary
DaVita delivered a strong Q2, with net income surging to $265.4 million ($4.02/share) from $199.3 million ($2.58/share) a year ago. Revenue climbed 5.2% to $3.55 billion. The results reinforce the full-year adjusted EPS guidance of $14.10–$15.20 issued earlier today, which sits above consensus. The beat on both top and bottom lines suggests operational momentum is accelerating. With the stock near $215, the guidance implies a forward P/E of roughly 14–15x, leaving room for multiple expansion if execution continues.
At the time of this announcement, DVA was trading at $214.99 on NYSE in the Life Sciences sector, with a market capitalization of approximately $14.6B. The 52-week trading range was $101.00 to $247.49. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: dpa-AFX.